Quince Therapeutics (QNCX) Earnings Date & Reports

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

QNCX is expected to report earnings to fall 34.12% to -22 cents per share on August 12

Quince Therapeutics QNCX Stock Earnings Reports

Q2'25

Est.

$-0.22

Q1'25

Missed

by $0.15

Q4'24

Missed

by $0.10

Q3'24

Missed

by $0.03

Q1'23

Missed

by $0.03

The last earnings report on May 13 showed earnings per share of -34 cents, missing the estimate of -18 cents. With 478.29K shares outstanding, the current market capitalization sits at 37.13M.

View a ticker or compare two or three

Compare

QNCX